For the quarter ending 2025-09-30, CERS had -$322K decrease in cash & cash equivalents over the period. $94K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -20 | -13,433 |
| Depreciation and amortization | 382 | 651 |
| Stock-based compensation | 5,624 | 12,316 |
| Non-cash operating lease cost | -581 | -1,336 |
| Net loss on sale of available-for-sale securities | -3 | -2 |
| Unrealized gain on investments | 70 | 128 |
| Non-cash interest expense | 101 | 197 |
| Foreign currency remeasurement loss (gain) | 361 | -508 |
| Accounts receivable | -1,438 | 1,226 |
| Inventories | -704 | 12,210 |
| Prepaid and other assets | 1,258 | 811 |
| Accounts payable | -4,480 | 7,842 |
| Accrued liabilities and other non-current liabilities | -787 | 853 |
| Deferred revenue | 70 | 813 |
| Net cash (used in) provided by operating activities | 1,927 | -3,290 |
| Capital expenditures | 1,833 | 589 |
| Purchases of investments | 7,288 | 20,477 |
| Proceeds from maturities and sale of investments | 6,612 | 18,788 |
| Net cash used in investing activities | -2,509 | -2,278 |
| Net proceeds from equity incentives | 269 | 326 |
| Net costs from public offerings | 52 | -87 |
| Net proceeds from (payment on) revolving line of credit | -1 | 703 |
| Proceeds from loans, net of issuance costs | 0 | 0 |
| Net cash provided by financing activities | 320 | 942 |
| Effect of exchange rates on cash, cash equivalents, and restricted cash | -60 | 396 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | -322 | -4,230 |
| Cash and cash equivalents at beginning of period | 21,361 | - |
| Cash and cash equivalents at end of period | 16,809 | - |
CERUS CORP (CERS)
CERUS CORP (CERS)